WES:ASX
Wesfarmers Limited
Data as of 2026-03-10 - not real-time
A$75.37
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Wesfarmers is trading well below its 20‑day, 50‑day and 200‑day moving averages, signaling a bearish technical backdrop, yet the RSI is deep in oversold territory and volume has been picking up, hinting at a possible short‑term bounce. Fundamentally, the company shows modest revenue growth, strong ROE and a healthy dividend yield, but its price‑to‑earnings and price‑to‑book multiples are markedly above peers, and a DCF model places fair value far below the current market price.
The balance sheet carries a high debt‑to‑equity ratio, though cash flow generation remains robust enough to sustain the dividend. Analyst consensus is neutral, and the lack of material news leaves the outlook driven primarily by internal metrics. Investors should weigh the attractive yield against the overvaluation and leverage concerns before deciding on positioning.
The balance sheet carries a high debt‑to‑equity ratio, though cash flow generation remains robust enough to sustain the dividend. Analyst consensus is neutral, and the lack of material news leaves the outlook driven primarily by internal metrics. Investors should weigh the attractive yield against the overvaluation and leverage concerns before deciding on positioning.
Trading Recommendations
Short Term
< 1 yearhold
Conviction: 6/10
Key Factors
- Oversold technical indicators suggest a near‑term support bounce
- Increasing volume adds confidence to short‑term stability
- High leverage tempers enthusiasm despite dividend appeal
Medium Term
1–3 yearshold
Conviction: 5/10
Key Factors
- Valuation remains above fair‑value estimates
- Modest revenue growth limits upside potential
- Sustainable dividend provides income while price pressure persists
Long Term
> 3 yearssell
Conviction: 4/10
Key Factors
- Persistent overvaluation relative to fundamentals
- Elevated debt levels could constrain future investment
- Limited growth outlook in a competitive consumer cyclical sector
Key Metrics & Analysis
Financial Health
Revenue Growth3.10%
Profit Margin6.60%
P/E Ratio27.9
ROE36.39%
ROA9.00%
Debt/Equity161.51
P/B Ratio10.9
Op. Cash FlowA$4.5B
Free Cash FlowA$3.3B
Technical Analysis
TrendBearish
RSI29.3
SupportA$73.32
ResistanceA$89.47
MA 20A$81.84
MA 50A$82.45
MA 200A$85.25
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Fair ValueA$35.26
Target PriceA$81.24
Upside/Downside7.79%
GradeOvervalued
TypeValue
Dividend Yield2.86%
Risk Assessment
Beta0.25
Volatility25.38%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.